In lymphoid leukemia, there is evidence that Wnt5a induces ROR1/ROR2 hetero-oligomerization and Rac1 activation [110], and that Wnt5a presence might offer a survival advantage [111]. This evidence concerns the gene WNT5A and lymphoid leukemia.